Cherry Hill Mortgage Investment Corp (CHMI)
NYSEReal EstateReit - MortgageSnapshot 2026-09-04
$2.96+0.34%
Close 2026-09-04 · 1-day change
NYSEReal EstateReit - MortgageSnapshot 2026-09-04
QuarterlyIQ Insights · CHMI
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 8 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $2.96 CHMI trades at 6.0× p/e, below its 9.7× p/e peer median. Our $5.66 fair value sits well above the price. We hold it with medium confidence: this sector is better valued on book value or cash flow than the earnings/sales multiple shown here. Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| ddm gordon | 12M | $9.42 | — | — | TTM | high |
| graham number | 12M | $8.29 | — | — | TTM | high |
| Peer P/FCF | 12M | $5.14 | 8.1 | 0.63 | TTM | high |
| Peer P/FFO | 12M | $4.52 | 9.7 | 0.46 | TTM | high |
| Peer P/S | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
Below average on quality vs scored peers
A second lens on the 12-month fair value: for companies that score high on measured quality (profitability, balance-sheet safety, earnings stability), this read trusts more of today's profit margins instead of averaging them toward their multi-year history the way the headline number does. Shown alongside the fair value above, not in place of it. A diagnostic, not a price target or a buy/sell signal.
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
No fragility gates fired.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks cheaper than most peers in the same business.
Richer than its own typical valuation.
Trailing four: 2025-Q2, 2025-Q3, 2026-Q1, 2026-Q2
Direction of the business behind the multiple. Bands are backend reads; trailing-12-month basis.
| $2.98 |
| 1.8 |
| 1.69 |
| TTM |
| high |
| residual income | 12M | $6.21 | — | — | TTM | high |
| Own P/E history | 12M | $2.64 | 5.4 | 0.49 | TTM | high |
| triangulated | 12M | $4.54 | 9.7 | 0.47 | Triangulated | high |
| Peer P/FCF | 3Y | $7.81 | 8.1 | 0.96 | Hist. CAGR(prov.) | medium |
| Peer P/S | 3Y | $4.36 | 1.8 | 2.47 | Hist. CAGR(prov.) | medium |
| Own P/E history | 3Y | $4.14 | 5.4 | 0.77 | Hist. CAGR(prov.) | medium |
| Peer P/FCF | 5Y | $10.33 | 8.1 | 1.27 | Hist. CAGR(prov.) | high |
| Peer P/S | 5Y | $5.62 | 1.8 | 3.18 | Hist. CAGR(prov.) | high |
| Own P/E history | 5Y | $5.33 | 5.4 | 0.99 | Hist. CAGR(prov.) | high |